Should the aspirin (Acetyl salicylic acid) be stopped before trans-urethral surgery?

Indian Journal of Urology

Volumn 22, Issue 1, 2006, Pages 59-60

  Gourabathini, Siva ^a   Kekre, Nitin ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746623001     PISSN: 09701591     EISSN: None     Source Type: Journal    
DOI: 10.4103/0970-1591.24658     Document Type: Article

References (10)

1. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86.
2. Samama CM, Bastien O, Forestier F, Denninger MH, Isetta C, Juliard JM, et al. French Society of Anesthesiology and Intensive Care. Antiplatelet agents in the peri-operative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement. Can J Anaesth 2002;49:S26-35.
3. Fijnheer R, Urbanus RT, Nieuwenhuis HK. Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary. Ned Tijdschr Geneeskd 2003;147:21-5
4. Ala-Opas MY, Gronlund SS. Blood loss in long-term aspirin users undergoing transurethral prostatectomy. Scand J Urol Nephrol 1996;30:203-6.
5. Wierod FS, Frandsen NJ, Jacobsen JD, Hartvigsen A, Olsen PR. Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998;32:120-2.
6. Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy - a prospective, randomized, double-blind, placebo -controlled study. Scand J Urol Nephrol 2000;34:194-8.
7. Maan Z, Cutting CW, Patel U, Kerry S, Pietrzak P, Perry MJ, et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 2003;91:798-800.
8. Mitchell SM, Sethia KK. Hazards of aspirin withdrawal before transurethral prostatectomy. BJU Int 1999;84:530.
9. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005;257:399-414.
10. Connor SE, Wingate JP. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol 1999;54:598-603.